Related Experiment Video

Updated: Mar 17, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

New therapeutic strategies for malignant pleural mesothelioma

Mara A Bonelli1, Claudia Fumarola1, Silvia La Monica1

  • 1Unit of Experimental Oncology, Department of Clinical and Experimental Medicine, University of Parma, Via Volturno 39, 43126 Parma, Italy.

Biochemical Pharmacology
|July 20, 2016
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a rare cancer with limited treatment options. This review explores targeted therapies and immune checkpoint inhibitors, highlighting the urgent need for novel approaches to improve survival for this aggressive disease.

Area of Science:

  • Oncology
  • Mesothelioma Research
  • Cancer Therapeutics

Background:

  • Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos exposure.
  • Current treatments like cisplatin/pemetrexed offer limited survival benefits (12 months OS, <6 months PFS).
  • The incidence of MPM is rising, necessitating urgent development of new therapies.

Purpose of the Study:

  • To review current pre-clinical and clinical data on targeted therapy for MPM.
  • To evaluate the efficacy of immune checkpoint inhibition in mesothelioma treatment.
  • To discuss future perspectives for novel therapeutic strategies in MPM.

Main Methods:

  • Comprehensive literature review of pre-clinical studies.
  • Analysis of clinical trial data for targeted agents and immunotherapies.
  • Synthesis of information on molecular pathogenesis and target identification.

Main Results:

  • Targeted therapy is not standard for MPM due to challenges in target definition and trial design.
  • Emerging data suggests potential for targeted agents and immune checkpoint inhibitors.
  • Further research is crucial for understanding MPM's molecular drivers.

Conclusions:

  • Novel therapeutic approaches, including targeted therapy and immunotherapy, are critically needed for MPM.
  • Improved understanding of MPM's molecular landscape is essential for developing effective treatments.
  • Future research should focus on better target identification and optimized clinical trial designs.
Keywords:
ImmunotherapyMPMTarget therapy

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.8K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
872
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
984
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
624
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.3K